(Q57479549)
Statements
A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression (English)
0 references
15 May 2006
0 references
67
0 references
05
0 references
798-806
0 references